EU Conditional Approval: Gene Editor to Treat Blood Diseases EU Conditional Approval: Gene Editor to Treat Blood Diseases

The single-dose therapy involves treating and editing patient stem cells ex vivo, then reinfusing them.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news